A 2021 update: Approach to asthma management in adults

N. Schellack; A. Truter; P. N. Ntuli; N. Mokwele; K. Mogale; A. Esterhuizen

A 2021 update: Approach to asthma management in adults

N. Schellack^*, A. Truter, P. N. Ntuli, N. Mokwele, K. Mogale, A. Esterhuizen

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma.

Original language	English
Pages (from-to)	17-24
Number of pages	8
Journal	SA Pharmaceutical Journal
Volume	88
Issue number	4
Publication status	Published - 31 Aug 2021
Externally published	Yes

Keywords

Asthma
Bronchodilator
Inhaled corticosteroid
LABA
Peak expiratory flow
SABA
Spirometry
β-agonist

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{356a7dcd5dd3449d8b023677673dbe22,

title = "A 2021 update: Approach to asthma management in adults",

abstract = "Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma.",

keywords = "Asthma, Bronchodilator, Inhaled corticosteroid, LABA, Peak expiratory flow, SABA, Spirometry, β-agonist",

author = "N. Schellack and A. Truter and Ntuli, {P. N.} and N. Mokwele and K. Mogale and A. Esterhuizen",

year = "2021",

month = aug,

day = "31",

language = "English",

volume = "88",

pages = "17--24",

journal = "SA Pharmaceutical Journal",

issn = "2221-5875",

publisher = "Medpharm Publications",

number = "4",

}

TY - JOUR

T1 - A 2021 update

T2 - Approach to asthma management in adults

AU - Schellack, N.

AU - Truter, A.

AU - Ntuli, P. N.

AU - Mokwele, N.

AU - Mogale, K.

AU - Esterhuizen, A.

PY - 2021/8/31

Y1 - 2021/8/31

N2 - Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma.

AB - Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma.

KW - Asthma

KW - Bronchodilator

KW - Inhaled corticosteroid

KW - LABA

KW - Peak expiratory flow

KW - SABA

KW - Spirometry

KW - β-agonist

UR - http://www.scopus.com/inward/record.url?scp=85114410031&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:85114410031

SN - 2221-5875

VL - 88

SP - 17

EP - 24

JO - SA Pharmaceutical Journal

JF - SA Pharmaceutical Journal

IS - 4

ER -

A 2021 update: Approach to asthma management in adults

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this